期刊文献+

卡托普利治疗急性心肌梗死合并心房颤动的临床观察 被引量:2

下载PDF
导出
摘要 目的 观察卡托普利治疗急性心肌梗死合并心房颤动的临床疗效。方法 比较卡托普利治疗组以及对照组两组的阵发性心房颤动再发率、转为持续性心房颤动的发生率,以及缺血性相关事件发生率。结果 急性心肌梗死合并心房颤动卡托普利治疗组阵发性心房颤动再发5例,占12.2%,转为持续性心房颤动的发生3例,占7.3%,以及缺血相关事件发生率为10例,占24.4%,明显低于对照组16例,占39.0%,两组相比较具有统计学意义(P<0.05)。结论 卡托普利治疗急性心肌梗死合并心房颤动,降低了心房颤动的复发率,减少其缺血性事件的发生率,并维持窦性心律,疗效持久。
作者 范卫华
出处 《中国医药科学》 2012年第1期94-94,96,共2页 China Medicine And Pharmacy
  • 相关文献

参考文献6

  • 1Joern S,Gabor D,Bernard J,et al.Atrial fibrillation in acute myocardialinfarction:a systematic review of the incidence,clinical features and prognosticimplications[J].Eur.Heart J,2009,3(30):1038-1045.
  • 2张卡,张效民.胺碘酮联合卡托普利治疗阵发性心房颤动的疗效观察[J].河南职工医学院学报,2010,22(2):136-137. 被引量:1
  • 3Ole DP,Steen Z,Abildstrom MM,et al.Increased risk of sudden and nonsuddencardiovascular death in patients with atrial fibrillation/flutter followingacute myocardial infarction[J].European Heart Journal,2008,3(27):290-295.
  • 4郝俊华,穆金兴,王连芹,齐丽平.卡托普利维持心房颤动复律后窦性心律及其对左心房的影响[J].山东医药,2008,48(29):58-59. 被引量:2
  • 5Galcera TA,Melgarejo MA.Padilla-Serrano,et al.Significance of atrialfibrillation in octogenarian patients with acute myocardial infarction[J].Eur JHeart Fail Suppl,2008,7(7):99-100.
  • 6Zusman O,Amit G,Gilutz H,et al.The significance of new onset atrialfibrillation complicating acute myocardial infarction[J].Clin Res Cardiol,2011,9(11):187-190.

二级参考文献9

共引文献1

同被引文献16

  • 1Dharmarajan K, Hsieh AF, Lin Z, et al. Diagnoses and timing of 30 - day readmissions after hospitalization for heart failure, acute myocardialinfarc- tion, or pneumonia [ J ]. JAMA, 2013,309 (4) : 355 - 363.
  • 2McHugh MD, Ma C. Hospital nursing and 30 - day readmissions among Medicare patients with heart failure, acute myocardial infarction, and pneu- monia[J]. Med Care,2013,51 ( 1 ) : 52 - 59.
  • 3Kntmholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocar- dial infarction, heart failure, or pneumonia[J] . JAMA, 2013, 309(6) : 587 - 593.
  • 4Husebye T, Eritsland J, MUller C, et al. Levosimendan in acute heart failure following primary pereutaneous coronary intervention -treated acute ST- elevation myocardial infarction. Results from the LEAF trial: a rando- mized, placebo - controlled study [ J] . Eur J Heart Fail, 2013, 15 (5) : 565 - 572.
  • 5Hara M, Sakata Y, Nakatani D, et al. Low levels of serum n - 3 polyunsatu- rated fatty acids are associated with worse heart failure -free survival in patients after acutcmyocardial infarction[J]. Circ J, 2013,77 (1): 153- 162.
  • 6Rossignol P, M6nard J, Fay R, et al. Eplerenone survival benefits in heart failure patients post- myocardial infarction are independent from its di- uretic and potassium-spariug effects. Insights from an EPHESUS (Eplerenone Post - Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudyiJ]. J Am Coil Cardiol,2011,58(19): 1 958- 1 966.
  • 7Dobre D, Rossignol P, Murin J, et al. Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: in- sights from the EPHESUS trial[J]. Eur J Heart Fail, 2013,15 (2): 221 - 227.
  • 8Ersbll M, Valeur N, Mogensen UM, et al. Prediction of all - cause mor- tality and heart failure admissions from global left ventricular longitudinal strain in patients with acutemyocardial infarction and preserved left ven- tricular ejection fraction[J]. J Am Coll Cardiol,2013,61 (23): 2 365 - 2 373.
  • 9Shamshad F, Kenchaiah S, Finn PV, et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT) [ J ]. Am Heart J, 2010,160 ( 1 ) : 145 - 151.
  • 10张冬梅.胺碘酮治疗急性心肌梗死合并快速心房颤动的观察及护理[J].中国基层医药,2009,16(9):1715-1716. 被引量:2

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部